JP2012525121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525121A5 JP2012525121A5 JP2012507624A JP2012507624A JP2012525121A5 JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5 JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- tumor
- associated antigen
- antibody
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 104
- 108020004707 nucleic acids Proteins 0.000 claims 95
- 102000039446 nucleic acids Human genes 0.000 claims 95
- 206010028980 Neoplasm Diseases 0.000 claims 68
- 239000000427 antigen Substances 0.000 claims 50
- 102000036639 antigens Human genes 0.000 claims 50
- 108091007433 antigens Proteins 0.000 claims 50
- 238000000034 method Methods 0.000 claims 20
- 239000003795 chemical substances by application Substances 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
- 201000011510 cancer Diseases 0.000 claims 9
- 230000000295 complement effect Effects 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 9
- 210000001744 T-lymphocyte Anatomy 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 230000002159 abnormal effect Effects 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 3
- 239000000032 diagnostic agent Substances 0.000 claims 3
- 229940039227 diagnostic agent Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 108020004459 Small interfering RNA Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 230000001461 cytolytic effect Effects 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010061968 Gastric neoplasm Diseases 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000037841 lung tumor Diseases 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 208000023958 prostate neoplasm Diseases 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000001875 tumorinhibitory effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17387109P | 2009-04-29 | 2009-04-29 | |
| EP09005931.2 | 2009-04-29 | ||
| US61/173,871 | 2009-04-29 | ||
| EP09005931A EP2249159A1 (en) | 2009-04-29 | 2009-04-29 | Identification of tumor-associated markers for diagnosis and therapy |
| PCT/EP2010/002490 WO2010124812A2 (en) | 2009-04-29 | 2010-04-22 | Identification of tumor-associated markers for diagnosis and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012525121A JP2012525121A (ja) | 2012-10-22 |
| JP2012525121A5 true JP2012525121A5 (OSRAM) | 2013-05-30 |
Family
ID=41100608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507624A Pending JP2012525121A (ja) | 2009-04-29 | 2010-04-22 | 診断および治療のための腫瘍関連マーカーの同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120070430A1 (OSRAM) |
| EP (2) | EP2249159A1 (OSRAM) |
| JP (1) | JP2012525121A (OSRAM) |
| AU (1) | AU2010243863A1 (OSRAM) |
| CA (1) | CA2760395A1 (OSRAM) |
| WO (1) | WO2010124812A2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2562721A (en) * | 2017-05-16 | 2018-11-28 | Fastbase Solutions Ltd | Kits, methods and their uses for detecting cell-cell interactions in a sample |
| WO2023244744A2 (en) * | 2022-06-15 | 2023-12-21 | Nonexomics, Inc. | Compositions and methods for treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US20070042392A1 (en) * | 2000-02-03 | 2007-02-22 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| DK2796553T3 (da) | 2000-03-30 | 2019-09-30 | Whitehead Inst Biomedical Res | Rna-sekvensspecifikke formidlere af rna-interferens |
| JP2006517788A (ja) * | 2002-12-20 | 2006-08-03 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 |
| DE102005013846A1 (de) * | 2005-03-24 | 2006-10-05 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| US20070231822A1 (en) * | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| WO2010065940A1 (en) * | 2008-12-04 | 2010-06-10 | The Regents Of The University Of California | Materials and methods for determining diagnosis and prognosis of prostate cancer |
-
2009
- 2009-04-29 EP EP09005931A patent/EP2249159A1/en not_active Withdrawn
-
2010
- 2010-04-22 EP EP10716294A patent/EP2425252A2/en not_active Withdrawn
- 2010-04-22 US US13/266,368 patent/US20120070430A1/en not_active Abandoned
- 2010-04-22 WO PCT/EP2010/002490 patent/WO2010124812A2/en not_active Ceased
- 2010-04-22 JP JP2012507624A patent/JP2012525121A/ja active Pending
- 2010-04-22 AU AU2010243863A patent/AU2010243863A1/en not_active Abandoned
- 2010-04-22 CA CA2760395A patent/CA2760395A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12235270B2 (en) | Depleting tumor-specific tregs | |
| JP2007537197A5 (OSRAM) | ||
| ES2583754T3 (es) | Productos génicos expresados de manera diferencial en tumores y utilización de los mismos | |
| JP2010047597A5 (OSRAM) | ||
| JP2007506417A5 (OSRAM) | ||
| JP2008537546A5 (OSRAM) | ||
| JP2006516190A5 (OSRAM) | ||
| JP2010063458A5 (OSRAM) | ||
| RU2013113439A (ru) | Идентификация опухолеассоциированных антигенов для диагностики и терапии | |
| JP2014524746A5 (OSRAM) | ||
| DE502005009602D1 (de) | Identifizierung von oberflächen-assoziierten antigenen für die tumordiagnose und -therapie | |
| JP2008508861A5 (OSRAM) | ||
| AU2020322440A2 (en) | Compositions and methods of using C/EBP alpha saRNA | |
| JP2005519608A5 (OSRAM) | ||
| DK2984108T3 (en) | Anti-s100a7 antibodies for the treatment and diagnosis of cancer | |
| RU2433136C2 (ru) | Новый ассоциированный с раком антиген | |
| JP2007526759A5 (OSRAM) | ||
| CN109709335B (zh) | 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用 | |
| JP2012525121A5 (OSRAM) | ||
| CN106701902B (zh) | Foxr2基因和表达产物在肝癌诊断与治疗中的应用 | |
| JP2009523004A5 (OSRAM) | ||
| CN110305963A (zh) | 一种食管癌分子标志物及其应用 | |
| CN110713544A (zh) | 融合基因plekha6-ntrk3及其在lch中的应用 | |
| CN111139299B (zh) | Josd2蛋白在制备治疗恶性肿瘤药物中的应用 | |
| US9581598B2 (en) | Diagnosis and treatment of brain tumor |